XpresSpa Group

XWELL, Inc. provides global travel health and wellness services. It operates through the following segments: XpresSpa, XpresTest, Treat, and Corporate and Other. The XpresSpa segment offers travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment deals with diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Treat segment consists of access to integrated care which can seamlessly fit into a post-pandemic world and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information all in one place. The company was founded by Jonathan Medved and David Goldfarb on January 9, 2006 and is headquartered in New York, NY.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

XWELL, Inc. provides global travel health and wellness services. It operates through the following segments: XpresSpa, XpresTest, Naples Wax Center, Treat, and Corporate & Other. The XpresSpa segment offers travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment deals with diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Naples Wax Center segment is focused on the products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers. The company was founded by Jonathan Medved and David Goldfarb on January 9, 2006 and is headquartered in New York, NY.

XpresSpa is redefining itself into health and wellness as COVID testing begins.

XpresSpa Transforms Into XpresCheck

Expected to Commence Operations by November

XpresSpa Group Begins Construction of New XpresCheck™ COVID-19 Testing Facility at Logan International Airport in Boston

XpresSpa (XSPA) is in the news Tuesday after announcing a business update concerning the novel coronavirus that boosted XSPA stock. The post XpresSpa News: Why XSPA Stock Is Surging 9% Today appeared first on InvestorPlace.

XpresSpa News: Why XSPA Stock Is Surging 9% Today

XpresSpa Group Inc., a popular fixture in airports, said Tuesday it will begin rapid testing for COVID-19 at JFK and Newark airports on Wednesday. "We believe rapid COVID-19 testing at airports can play a major role in slowing the virus spread and decreasing the risk of new community outbreaks linked to travel as cases continue to rise throughout many states," XpressSpa Chief Executive Doug Satzman said in a statement.

Airport fixture XpresSpa to start rapid COVID-19 tests at JFK and Newark airports, shares jump

Launching Rapid Testing for COVID-19 at JFK and Newark Airports Tomorrow; All Future Locations will Offer Rapid TestingWorking with Major Airlines in Supporting Air Bridges between U.S. and International CitiesEngaged in Discussions with Multiple Emerging Health Passport Apps

XpresCheck™ Provides Business Update

XpresSpa had a clever idea to cope with the economys' collapse, but investors in XSPA stock are waiting for action to justify their bets.
The post With Early Deadline Misses, Things Are Looking Desperate for XpresSpa Stock appeared first on InvestorPlace.

With Early Deadline Misses, Things Are Looking Desperate for XpresSpa Stock

XSPA stock soared as the company pivoted to in-airport coronavirus testing. But even if the pivot works, it's unclear what comes next.

The Key Question Surrounding XpresSpa Group Right Now

If you had doubts about XSPA stock when it was more expensive, that's understandable. Today, though, the shares trade at a discount price.

Now at a Nice Price, XpresSpa Stock Is Much More Intriguing

XpresSpa has refused to release any information about the financial performance of its testing business. That's a very bad sign for XSPA stock.

The Proposition for XpressSpa Stock Looks Worse and Worse by the Day

XpresSpa Group’s $35 million direct offering of equity units knocked almost 20% off the value of XSPA stock. Should you buy on the dip?

XpresSpa Group’s Stock Drop Ignores the Potential of Pivot to Virus Testing

XpresSpa (NASDAQ: XSPA) shares are trading lower on Wednesday after the company announced a $35.5 million registered direct offering priced at-the-market under Nasdaq rules.

Why XpresSpa's Stock Is Trading Lower Today

NEW YORK, Aug.  26, 2020  (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced that it has entered into securities purchase agreements with several healthcare-focused and other institutional investors to purchase 11,216,932 of its shares of common stock (or common stock equivalents in lieu thereof) and short-term warrants to purchase up to an aggregate of 11,216,932 shares of common stock, in a registered direct offering priced at-the-market under Nasdaq rules.  The combined purchase price for one share of common stock (or common stock equivalent) and a warrant to purchase one share of common stock is $3.15. The warrants have an exercise price of $3.02 per share, will be immediately exercisable, and will expire 24 months from the issue date.

XpresSpa Group Announces $35.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

XSPA stock is having a terrific year. Bullish investors believe it can turn into a viable resource for Covid-19 testing.

XpresSpa Still Presents More Questions Than Answers

XpresSpa Group, Inc’s (NASDAQ: XSPA) shares closed over 18% on Monday as the company announced it had cut the waiting time for COVID-19 tests conducted at airports from 48 hours to under 15 minutes.

XpresSpa Shares Jump Over 18%, As Company Says It Has Expedited Airport COVID-19 Screening

XpresCheck™ to Begin Rapid Testing for COVID-19

XpresCheck™ Shatters the Time Barrier in Airport COVID-19 Testing 

New Site Builds on Pilot Program at JFK International Airport’s Terminal 4

XpresSpa Group Announces the Opening of XpresCheck™ COVID-19 Testing Facility at Newark Liberty International Airport’s Terminal B on August 17, 2020

Moving from spa services retailing into Covid-19 testing is yet to show tangible results but plans are already afoot for testing other communicable diseases as well as administering seasonal flu vaccinations.

XpresSpa Opens Second Airport Covid-19 Test Center At Newark As Losses Mount

XpresSpa Group, Inc. (XSPA) CEO Doug Satzman on Q2 2020 Results - Earnings Call Transcript

XpresSpa Group (XSPA) earnings for the health and wellness company's second quarter of 2020 have XSPA stock soaring higher after-hours Wednesday.
The post XpresSpa Group Earnings: XSPA Stock Grows 6% on Q2 Results appeared first on InvestorPlace.

XpresSpa Group Earnings: XSPA Stock Grows 6% on Q2 Results

Views Addressable Market for XpresCheck™ of 60 U.S. Airports in Addition to International Opportunities

XpresSpa Group Provides Business Update and Announces Second Quarter 2020 Financial Results

With its namesake spa business closed, XpresSpa has moved into Covid-19 testing. But it's unclear if this will be a winner for XSPA stock.

Many Questions Linger For XpresSpa Stock

It popped and then dropped, but that won't necessarily be the endgame for contentious yet promising XSPA stock.
The post It’s Now Time to Flip Bullish on XpresSpa appeared first on InvestorPlace.

It’s Now Time to Flip Bullish on XpresSpa

XSPA stock isn't a pump-and-dump penny stock scheme; this is an innovative company executing strongly against a huge long-term opportunity.
The post Why XpresSpa Is Much More than the Bears Think appeared first on InvestorPlace.

Why XpresSpa Is Much More than the Bears Think

Conference Call and Webcast Scheduled for 5:00 PM ET Conference Call and Webcast Scheduled for 5:00 PM ET

XpresSpa Group to Provide Business Update and Announce Second Quarter 2020 Financial Results on August 19, 2020

Plans to open a second testing facility revealed more challenges facing the company.

News for XpresSpa Group Stock (XSPA)